Sort
16,300 grants matching “fatty liver disease”
The Saint Louis University Component of the NASH Clinical Research Network
$38,975Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2013 · DK
Impaired adipogenesis in insulin resistance: pilot clinical and in-vitro studies
$38,962Richard E Pratley · University Of Vermont & St Agric College · R21 · FY2010 · DK
ABHD5 and PNPLA3 in the development of fatty liver disease
$38,920Alexander C Yang · Wayne State University · F30 · FY2019 · DK
Imaging for phenotyping of rodent obesity models
$38,832Sreenath Narayan · Case Western Reserve University · F30 · FY2012 · DK
Ethanol-mediated inhibition of the S1P lyase results in disruption of apoptotic machinery and lymphocyte egress from lymphoid tissue
$38,796Jesse Gelles-Hurwitz · Icahn School Of Medicine At Mount Sinai · F31 · FY2016 · AA
Tumor-cell intrinsic and extrinsic determinants of drug resistance and metastasis
$38,693Mark Primeaux · University Of Nebraska Medical Center · F99 · FY2024 · CA
Predictors of Histologic Severity in Non-Alcoholic Fatty Liver Disease (NAFLD)
$38,630University Of Michigan At Ann Arbor · M01 · FY2004 · RR
Chronic binge alcohol in SIV infection: impact of adipose tissue stiffness on metabolic dysfunction
$38,605Jonquil M Poret · Lsu Health Sciences Center · F31 · FY2022 · AA
Interrogating Liver Macrophage LXR Signaling in Health and Non-Alcoholic Fatty Liver Disease
$38,513Hunter R. Bennett · University Of California, San Diego · F30 · FY2021 · DK
TORS - Interdisciplinary Research Training Program, Project 8 of 10 TL1
$38,502Joyce J Repa · Ut Southwestern Medical Center · TL1 · FY2011 · DK
Depressing Nrip1 Reduces IGF1 Signaling Improves Metabolism and Extends Longevity
$38,448Rong Yuan · Southern Illinois University Sch Of Med · K01 · FY2017 · AG
Effects Of Androgen Deficiency on Glucose Homeostasis
$38,445Josephine Egan · National Institute On Aging · ZIA · FY2015 · AG
CEST AND T1RHO MRI OF LIVER FIBROSIS
$38,442Kewen Cai · University Of Pennsylvania · P41 · FY2011 · RR
Central mechanisms of fibroblast growth factor-21 to decrease hepatic triglycerides
$38,440Aki Terata-Bowers Chaffin · University Of California At Davis · F31 · FY2021 · DK
Hepatic Myeloid Cells Regulated by Obesity
$38,440Amrom E Obstfeld · Columbia University Health Sciences · F30 · FY2009 · DK
Summer Environmental Health Sciences Training Program
$38,431Russell Allen Prough · University Of Louisville · T35 · FY2018 · ES
ABHD5 and PNPLA3 in the development of fatty liver disease
$38,428Alexander C Yang · Wayne State University · F30 · FY2018 · DK
Role of SAMe in Pathogenesis and Treatment of Non-Alcholic Fatty Liver Disease
$38,417Shelly Chi-Loo Lu · University Of Southern California · R01 · FY2014 · AT
Imaging for phenotyping of rodent obesity models
$38,400Sreenath Narayan · Case Western Reserve University · F30 · FY2011 · DK
Regulation of hepatic lipid metabolism by novel protein BASIC
$38,294Lauren F Uchiyama · University Of California Los Angeles · F30 · FY2022 · DK
Maternal Liver Disease and Fatty Acid Oxidation Defects
$38,205University Of Missouri-Columbia · R01 · FY2005 · DK
The Role of FIT Proteins in Regulating Glucose and Lipid Metabolism
$38,200Diego Armando Miranda · Albert Einstein College Of Medicine · F31 · FY2011 · DK
Mechanisms and Tissue-Specific Contributions of Liver-Fatty Acid Binding Protein (LFABP) in Whole-Body Energy Homeostasis
$38,124Atreju Lackey · Rutgers, The State Univ Of N.J. · F31 · FY2018 · DK
Role of Hepatic FoxO1 in Atherosclerosis
$38,096Rebecca Anne Haeusler · Columbia University Health Sciences · F32 · FY2010 · HL
Investigating the hepatic toxicity of 3,3â-dichlorobiphenyl (PCB-11) in zebrafish (Danio rerio)
$38,024Monika Roy · University Of Massachusetts Amherst · F31 · FY2019 · ES